| display_id | version | name | description | label | displayTitle | sectionType | order | subSection_id | subSection_text |
|---|
| Disp14-1-1 | 1 | Demographics - Male | A summary of demographic characteristics (age, age group, gender, ethnicity, primary race, and height) for male subjects | Demog-M | Summary of Demographics (Male) | TitleHeader | 1 | GlobalDisp_TitleHeader_1 | Study CDISCPILOT01 |
| Disp14-1-1 | 1 | Demographics - Male | A summary of demographic characteristics (age, age group, gender, ethnicity, primary race, and height) for male subjects | Demog-M | Summary of Demographics (Male) | Title | 21 | Disp14-1-1_Title_1 | Table 14.1.1 |
| Disp14-1-1 | 1 | Demographics - Male | A summary of demographic characteristics (age, age group, gender, ethnicity, primary race, and height) for male subjects | Demog-M | Summary of Demographics (Male) | Title | 32 | Disp14-1-1_Title_2 | Summary of Demographics |
| Disp14-1-1 | 1 | Demographics - Male | A summary of demographic characteristics (age, age group, gender, ethnicity, primary race, and height) for male subjects | Demog-M | Summary of Demographics (Male) | Title | 43 | Disp14-1-1_Title_3 | Male Subjects |
| Disp14-1-1 | 1 | Demographics - Male | A summary of demographic characteristics (age, age group, gender, ethnicity, primary race, and height) for male subjects | Demog-M | Summary of Demographics (Male) | FootnoteFooter | 1 | Disp14-1-1_FnoteFooter_1 | Source dataset: adsl, Generated on: DDMONYYYY:HH:MM |
| Disp14-1-1 | 1 | Demographics - Male | A summary of demographic characteristics (age, age group, gender, ethnicity, primary race, and height) for male subjects | Demog-M | Summary of Demographics (Male) | Rowlabel Header | 1 | Disp14-1-1_RLbHd_1 | Characteristics |
| Disp14-1-2 | 1 | Demographics - Female | A summary of the demographic characteristics (age, age group, gender, ethnicity, primary race, and height) for female subjects | Demog-F | Summary of Demographics (Female) | TitleHeader | 1 | GlobalDisp_TitleHeader_1 | Study CDISCPILOT01 |
| Disp14-1-2 | 1 | Demographics - Female | A summary of the demographic characteristics (age, age group, gender, ethnicity, primary race, and height) for female subjects | Demog-F | Summary of Demographics (Female) | Title | 21 | Disp14-1-2_Title_1 | Table 14.1.2.1.2 |
| Disp14-1-2 | 1 | Demographics - Female | A summary of the demographic characteristics (age, age group, gender, ethnicity, primary race, and height) for female subjects | Disp14-1-2 | 1 | Demog-F | Summary of Demographics (Female) | Title | 32 | Disp14-1-1_Title_2 | Summary of Demographics |
| Disp14-1-2 | 1 | Demographics - Female | A summary of the demographic characteristics (age, age group, gender, ethnicity, primary race, and height) for female subjects | Demog-F | Summary of Demographics (Female) | Title | 43 | Disp14-1-2_Title_2 | Female Subjects |
| Disp14-1-212 | 1 | Demographics - Female | A summary of the demographic characteristics (age, age group, gender, ethnicity, primary race, and height) for female subjects | Demog-F | Summary of Demographics (Female) | FootnoteFooter | 1 | Disp14-1-1_FnoteFooter_1 | Source dataset: adsl, Generated on: DDMONYYYY:HH:MMMM |
| Disp14-1-2 | 1 | Summary of Demographics - Female | A summary of the demographic characteristics (age, age group, gender, ethnicity, primary race, and height) for female subjects | Disp14-1-2 | 1 | Demog-F | Summary of Demographics (Female) | Rowlabel Header | 1 | Disp14-1-1_RLbHd_1 | Characteristics |
| Disp14-3-1-1 | 1 | -3-1-1 | 1 | TEAE Summary | A summary of treatment-emergent AEs of different types (overall, related, serious, related serious, leading to death, related leading to death, leading to dose modification, and leading to treatment discontinuation) | TEAEAE_Summ | Overall Summary of Treatment-Emergent Adverse Events | TitleHeader | 1 | GlobalDisp_TitleHeader_1 | Study CDISCPILOT01 |
| Disp14-3-1-1 | 1 | -3-1-1 | 1 | TEAE Summary | A summary of treatment-emergent AEs of different types (overall, related, serious, related serious, leading to death, related leading to death, leading to dose modification, and leading to treatment discontinuation) | TEAEAE_Summ | Overall Summary of Treatment-Emergent Adverse Events | Title | 21 | Disp14-3-1-1_Title_1 | Table 14.3.1.1 |
| Disp14-3-1-1 | 1 | -3-1-1 | 1 | TEAE Summary | A summary of treatment-emergent AEs of different types (overall, related, serious, related serious, leading to death, related leading to death, leading to dose modification, and leading to treatment discontinuation) | TEAEAE_Summ | Overall Summary of Treatment-Emergent Adverse Events | Title | 32 | Disp14-3-1-1_Title_2 | Overall Summary of Treatment-Emergent Adverse Events |
| Disp14-3-1-1 | 1 | -3-1-1 | 1 | TEAE Summary | A summary of treatment-emergent AEs of different types (overall, related, serious, related serious, leading to death, related leading to death, leading to dose modification, and leading to treatment discontinuation) | TEAEAE_Summ | Overall Summary of Treatment-Emergent Adverse Events | Abbreviation | 1 | Disp14-3-1-1_Abbrv_1 | Note: TEAE=Treatment-Emergent Adverse Events. |
| Disp14-3-1-1 | 1 | TEAE Summary | A summary of treatment-emergent AEs of different types (overall, related, serious, related serious, leading to death, related leading to death, leading to dose modification, and leading to treatment discontinuation) | TEAE | Disp14-3-1-1 | 1 | AE_Summ | Overall Summary of Treatment-Emergent Adverse Events | Footnote | 1 | Disp14-3-1-1_Fnote_1 | [a] Dose Modification includes Dose Reduced; Drug Interrupted in the AE action taken with study treatment. |
| Disp14-3-1-1-1 | 1 | 1 | 1 | TEAE Summary | A summary of treatment-emergent AEs of different types (overall, related, serious, related serious, leading to death, related leading to death, leading to dose modification, and leading to treatment discontinuation) | TEAEAE_Summ | Overall Summary of Treatment-Emergent Adverse Events | FootnoteFooter | 21 | Disp14-3-1-1_FnoteFooter_21 | Source dataset: adae, Generated on: DDMONYYYY:HH:MM |
| Disp14-3-1-1 | 1 | TEAE Summary | A summary of treatment-emergent AEs of different types (overall, related, serious, related serious, leading to death, related leading to death, leading to dose modification, and leading to treatment discontinuation) | TEAE | Disp14-3-1-1 | 1 | AE_Summ | Overall Summary of Treatment-Emergent Adverse Events | Rowlabel Header | 1 | Disp14-3-1-1_RLbHd_1 | Categories, n (%) |